Paul-Scherrer Institute Archives - Investors in Healthcare

Home Tags Paul-Scherrer Institute

Analysis

One of the largest preclinical ADC deals: Taiho Pharma’s US$1.14bn acquisition...

Nick Herbert - 24th April 2025